Skip to content

Insider · CIK 0002034056

Shannon T Kelley

officer

Files at MDGL (MADRIGAL PHARMACEUTICALS, INC.). First filing Jan 17, 2025, latest Mar 5, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $215k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

MDGL: MADRIGAL PHARMACEUTICALS, INC.

MDGLOct 9, 2026 · close 471.75

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
21Weak
MDGLsell 610b5-1
MADRIGAL PHARMACEUTICALS, INC.
$139k
415 shares
-5%-
31Weak
MDGLsell 2
MADRIGAL PHARMACEUTICALS, INC.
$76k
277 shares
-3%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 5, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+3,187$0.00$010,477Mar 7, 2025
Mar 5, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+5,368$0.00$05,368Mar 7, 2025
Mar 3, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock10b5-1
-415$335.00$139k7,290Mar 5, 2025
Jan 17, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-277$273.41$76k7,705Jan 17, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Shannon T Kelley: insider trades and track record | InsiderTell